Public trust in the integrity of our research is something we earn every day. This policy explains how Sibel Health identifies and manages financial relationships that could influence — or appear to influence — the science we do.

At Sibel, we believe that scientific research should be guided by evidence, not by the personal financial interests of the people conducting it. When our scientists are funded by the U.S. Public Health Service (PHS), including the National Institutes of Health (NIH), they take on a responsibility not just to their funders, but to the public that ultimately benefits from — and pays for — their work.

This policy describes how we identify and manage financial relationships that could bias the design, conduct, or reporting of our PHS-funded research. It implements the federal requirements at 42 CFR Part 50, Subpart F (“Promoting Objectivity in Research”) and 45 CFR Part 94.

 

Why This Matters

Researchers often have legitimate, productive relationships with companies and other organizations — consulting, advisory roles, equity in start-ups they help build, royalties from inventions, paid speaking, sponsored travel. These relationships can be valuable. They can also create situations where a researcher’s financial interest in an outcome could shape, even unconsciously, the way a study is designed or reported.

Federal regulations require institutions like ours to take this risk seriously. So do we. A well managed disclosure process protects research participants, preserves the credibility of our published findings, and ensures that public funds are spent on objective science.

 

What Is a Financial Conflict of Interest?

Under the federal regulations, a Financial Conflict of Interest (FCOI) is a Significant Financial Interest held by a researcher, or by their spouse or dependent children, that we determine could directly and significantly affect the design, conduct, or reporting of PHS-funded research.

A Significant Financial Interest generally includes any of the following, when reasonably related to a researcher’s institutional responsibilities:

1. Publicly traded companies: payments and equity that, in total, exceed $5,000 over the past 12 months.
2. Privately held companies: payments over $5,000 in the past 12 months, or any amount of equity (including stock, stock options, or other ownership interests).
3. Intellectual property: income from patents, copyrights, or licenses.
4. Sponsored or reimbursed travel related to a researcher’s institutional responsibilities, with limited exceptions for travel paid by U.S. government agencies, U.S. higher education institutions, academic teaching hospitals, and affiliated research institutes.

Some things are not Significant Financial Interests — for example, salary paid by Sibel Health, royalties paid to a researcher under our institutional intellectual property policy, or income from mutual funds and retirement accounts that the researcher does not directly manage.

 

Who This Policy Applies To

This policy applies to anyone at Sibel Health who is responsible for the design, conduct, or reporting of PHS-funded research — regardless of title, position, or whether they work full-time. That includes principal investigators, co-investigators, faculty, staff scientists, postdoctoral fellows, students, and consultants who play a substantive role in the work.

It also applies to subrecipients — organizations and individuals that receive funding from us under a PHS award to perform a portion of the research.

 

What We Ask of Our Researchers

Disclosure

Researchers covered by this policy disclose their Significant Financial Interests to our designated review official:

1. When they apply for PHS funding;
2. At least once a year while a PHS-funded project is active; and
3. Within 30 days of acquiring or discovering a new Significant Financial Interest.

Training

Every covered researcher completes training on this policy and the federal regulations before participating in PHS-funded research, and at least every four years thereafter. We also retrain when the policy changes substantively, when someone joins us from another institution, or if we identify a compliance issue that warrants it.

Following Management Plans

When we identify an FCOI, we work with the researcher to put a written management plan in place. Researchers are expected to follow that plan throughout the life of the project.

 

How We Review and Manage Disclosures

Our designated review official examines every disclosure to determine two things, in order:

1. Is the financial interest related to the research? Could the research affect the value of the financial interest, or the other way around?
2. If it is related, does it rise to the level of an FCOI? Could the financial interest directly and significantly affect the design, conduct, or reporting of the research?

We complete this review and put a management plan in place before any PHS funds are spent on the project. If a new disclosure comes in mid-project — because a researcher joins the team or because circumstances change — we complete our review within 60 days.

Each management plan is tailored to the situation. Depending on the circumstances, it may include steps such as:

1. Public disclosure of the financial interest in publications, presentations, and (for human subjects research) participant consent documents;
2. Independent monitoring of the research;
3. Modifying the research plan;
4. Changing the researcher’s role or removing them from specific portions of the work;
5. Reducing or eliminating the financial interest; or
6. Ending the relationship that creates the conflict.

 

Reporting to NIH and Other PHS Agencies

Before any PHS funds are spent, and again each year that a project remains active, we report identified FCOIs to the funding agency. Our reports include the project number, the principal investigator, the name of the researcher with the conflict, the entity involved, the nature and value of the interest, how it relates to the research, and the key elements of our management plan.

If a retrospective review (described below) ever finds that bias affected the research, we promptly notify the funding agency and submit a mitigation report describing what happened and the steps we are taking to address it.

 

Information Available to the Public

Federal regulations require institutions to make certain information about FCOIs of senior and key personnel publicly available. We meet this requirement by responding to written requests within five business days. The information we provide includes:

1. The researcher’s name;
2. Their title and role on the project;
3. The name of the entity in which the financial interest is held;
4. The nature of the interest (for example, equity, consulting payments, royalties); and
5. The approximate value of the interest, expressed in the dollar ranges defined by the regulation.

To request this information, please use the submission form on our website. Information about a particular interest remains available for at least three years from the date it was most recently updated.

 

Working With Research Partners

When we collaborate with other organizations on PHS-funded research, we put written agreements in place that make clear which institution’s FCOI policy applies to the partner’s researchers. Partner organizations either certify that their own policy meets the federal regulation, or their researchers follow ours. Either way, partners are required to report any identified FCOIs to us in time for us to meet our own reporting deadlines.

 

When Issues Arise

Retrospective Review

If we discover that an FCOI was not identified or managed in time — for example, because a Significant Financial Interest was not disclosed when it should have been, or because a researcher did not follow a management plan — we conduct a retrospective review within 120 days. The review looks back at what happened during the period of noncompliance and asks whether the research itself was biased in its design, conduct, or reporting.

We document the review thoroughly: the reason it was triggered, who reviewed what, the findings, and the conclusions. If we identify bias, we submit a mitigation report to the PHS funding agency and describe the corrective actions we are taking.

Accountability

Researchers who fail to comply with this policy or with an approved management plan may face administrative action, up to and including termination of employment or appointment, suspension of research activities, and additional training requirements. We notify the funding agency where required by law or regulation.

Recordkeeping

We retain disclosure records, review documentation, management plans, and retrospective review materials for at least three years after the final expenditure report is submitted to the PHS, or longer where other federal record retention requirements apply.

Privacy and Confidentiality

To the extent permitted by law, we treat disclosures and management plan details as confidential. We share information only as required by federal regulations (including the public accessibility provisions described above), in response to legally compelled requests, or as needed to administer this policy.